Your browser doesn't support javascript.
loading
Risk factors of nonalcoholic fatty liver disease in lean body mass population: A systematic review and meta-analysis.
Alam, Shahinul; Eslam, Mohammad; Skm Hasan, Nazmul; Anam, Kamrul; Chowdhury, Mohammad Abdul Baker; Khan, Md Abdullah Saeed; Hasan, Mohammad J; Mohamed, Rosmawati.
Affiliation
  • Alam S; Department of Hepatology Bangabandhu Sheikh Mujib Medical University Dhaka Bangladesh.
  • Eslam M; Storr Liver Centre, Westmead Institute for Medical Research Westmead Hospital and University of Sydney Sydney New South Wales Australia.
  • Skm Hasan N; Department of Hepatology Shaheed Syed Nazrul Islam Medical College Kishoreganj Bangladesh.
  • Anam K; Department of Medical Gastroenterology Sheikh Russel National Gastroliver Institute and Hospital Dhaka Bangladesh.
  • Chowdhury MAB; Department of Emergency Medicine University of Florida College of Medicine Gainesville Florida USA.
  • Khan MAS; Meta analysis Division Pi Research Consultancy Center Dhaka Bangladesh.
  • Hasan MJ; Department of Pharmacology Shaheed Sayed Nazrul Islam Medical College Kishoreganj Bangladesh.
  • Mohamed R; Meta analysis Division Pi Research Consultancy Center Dhaka Bangladesh.
JGH Open ; 5(11): 1236-1249, 2021 Nov.
Article in En | MEDLINE | ID: mdl-34816009
The pathophysiology and risk factors of nonalcoholic fatty liver disease (NAFLD) among lean patients is poorly understood and therefore investigated. We performed a meta-analysis of observational studies. Of 1175 articles found through searching from Medline/PubMed, Banglajol, and Google Scholar by two independent investigators, 22 were selected. Data from lean (n = 6768) and obese (n = 9253) patients with NAFLD were analyzed; lean (n = 43 398) and obese (n = 9619) subjects without NAFLD served as controls. Age, body mass index, waist circumference, systolic blood pressure, and diastolic blood pressure (DBP) had significantly higher estimates in lean NAFLD patients than in lean non-NAFLD controls. Fasting blood sugar [MD(mean difference) 5.17 mg/dl, 95% CI(confidence interval) 4.14-6.16], HbA1c [MD 0.29%, 95% CI 0.11-0.48], and insulin resistance [HOMA-IR] [MD 0.49 U, 95% CI 0.29-0.68]) were higher in lean NAFLD patients than in lean non-NAFLD controls. All components of the lipid profile were raised significantly in the former group except high-density lipoprotein. An increased uric acid (UA) level was found to be associated with the presence of NAFLD among lean. Cardio-metabolic profiles of nonlean NAFLD patients significantly differs from the counter group. However, the magnitude of the difference of lipid and glycemic profile barely reached statistical significance when subjects were grouped according to lean and nonlean NAFLD. But DBP (slope: 0.19, P < 0.037), HOMA-IR (slope: 0.58, P < 0.001), and UA (slope: 0.36, P = 0.022) were significantly higher if NAFLD was present compared to that of non-NAFLD group. Lean and nonlean NAFLD patients are metabolically similar and share common risk factors.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Etiology_studies / Observational_studies / Risk_factors_studies / Systematic_reviews Language: En Journal: JGH Open Year: 2021 Type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Etiology_studies / Observational_studies / Risk_factors_studies / Systematic_reviews Language: En Journal: JGH Open Year: 2021 Type: Article